Novoheart can aid you in areas that include but are not limited to:

• Mapping and designing preclinical studies that involve human embryonic or induced pluripotent stem cell-derived cardiomyocytes
  • Drug discovery
  • Cardiotoxicity screening
  • Efficacy studies
  • Modelling disease-, mutation-, and ethnic-specific responses to drug compound
  • Functional assessment of disease states
  • Fundamental understanding
• Prototyping custom bioreactor designs
• Developing custom software for streamlining of screening platforms and analysis of acquired data